Patents by Inventor Kikuji Itoh
Kikuji Itoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240307463Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: June 7, 2024Publication date: September 19, 2024Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20240307462Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: May 28, 2024Publication date: September 19, 2024Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20220096568Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: July 9, 2021Publication date: March 31, 2022Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 11090343Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: February 3, 2020Date of Patent: August 17, 2021Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20200246399Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: February 3, 2020Publication date: August 6, 2020Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 10597427Abstract: The present invention provides a diabetes-inducing bacterium and use thereof, and a reagent and a detection method for detecting the bacterium. According to the present invention, enteric colonization of the diabetes-inducing bacterium can be prevented, and diabetes can be treated and/or prevented.Type: GrantFiled: September 26, 2014Date of Patent: March 24, 2020Assignee: AJINOMOTO CO., INC.Inventors: Keishi Kameyama, Kikuji Itoh
-
Patent number: 10588925Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: April 19, 2019Date of Patent: March 17, 2020Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 10555978Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: May 29, 2019Date of Patent: February 11, 2020Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20190282635Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: May 29, 2019Publication date: September 19, 2019Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20190282634Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: April 19, 2019Publication date: September 19, 2019Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 10328108Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: October 26, 2018Date of Patent: June 25, 2019Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 10322150Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: August 30, 2018Date of Patent: June 18, 2019Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20190046592Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: October 26, 2018Publication date: February 14, 2019Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20190030093Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: August 30, 2018Publication date: January 31, 2019Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 10092603Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: October 11, 2017Date of Patent: October 9, 2018Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Publication number: 20180153981Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: ApplicationFiled: October 11, 2017Publication date: June 7, 2018Applicant: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 9833483Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: March 29, 2017Date of Patent: December 5, 2017Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 9827276Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: March 29, 2017Date of Patent: November 28, 2017Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 9808519Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: May 9, 2017Date of Patent: November 7, 2017Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
-
Patent number: 9801933Abstract: It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.Type: GrantFiled: July 21, 2016Date of Patent: October 31, 2017Assignee: The University of TokyoInventors: Kenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue